Abbott Reveals Positive Data From Hepatitis C Drug Study

Published November 9, 2012

Abbott Reveals Positive Data From Hepatitis C Drug Study

Filed under: Drug Treatment Centers Seattle

(RTTNews.com) – Abbott Laboratories (ABT) Monday reported positive initial results for its drug combination to treat Hepatitis C in a Phase 2B study, with 99 percent of patients showing high cure rates. In the Aviator trial, 571 patients were …
Read more on NASDAQ

Medtronic Says Stent Successfully Treats Long Lesions and Small Vessels …

Filed under: Drug Treatment Centers Seattle

The Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) delivered successful clinical results, according to new data presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium for the treatment of long …
Read more on Equities.com